Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5187240
Max Phase: Preclinical
Molecular Formula: C18H25N6NaO4
Molecular Weight: 390.44
Associated Items:
ID: ALA5187240
Max Phase: Preclinical
Molecular Formula: C18H25N6NaO4
Molecular Weight: 390.44
Associated Items:
Canonical SMILES: CC(NCC(O)CC(=O)[O-])c1nnnn1CCCC(=O)NCc1ccccc1.[Na+]
Standard InChI: InChI=1S/C18H26N6O4.Na/c1-13(19-12-15(25)10-17(27)28)18-21-22-23-24(18)9-5-8-16(26)20-11-14-6-3-2-4-7-14;/h2-4,6-7,13,15,19,25H,5,8-12H2,1H3,(H,20,26)(H,27,28);/q;+1/p-1
Standard InChI Key: MRQXDLPJORVWDL-UHFFFAOYSA-M
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 390.44 | Molecular Weight (Monoisotopic): 390.2016 | AlogP: 0.26 | #Rotatable Bonds: 12 |
Polar Surface Area: 142.26 | Molecular Species: ACID | HBA: 8 | HBD: 4 |
#RO5 Violations: 0 | HBA (Lipinski): 10 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 3.77 | CX Basic pKa: 7.41 | CX LogP: -2.69 | CX LogD: -2.93 |
Aromatic Rings: 2 | Heavy Atoms: 28 | QED Weighted: 0.40 | Np Likeness Score: -1.35 |
1. Ulgheri F, Spanu P, Deligia F, Loriga G, Fuggetta MP, de Haan I, Chandgudge A, Groves M, Domling A.. (2022) Design, synthesis and biological evaluation of 1,5-disubstituted α-amino tetrazole derivatives as non-covalent inflammasome-caspase-1 complex inhibitors with potential application against immune and inflammatory disorders., 229 [PMID:34823899] [10.1016/j.ejmech.2021.114002] |
Source(1):